FDA recommends removing Avastin’s breast cancer indication
The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because the drug…
Oncology
Evidence-based interventions for depression in patients with cancer
Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society. Dana Jennings, in his New York Times…
New warning added for gonadotropin-releasing hormone agonists
The U.S. Food and Drug Administration has asked manufacturers to add new labeling warnings for gonadotropin-releasing hormone (GnRH) agonists, mostly used to treat men…
The role of pharmacogenomics in cancer
Oncology nurses have long appreciated that the “one size fits all” strategy—basing chemotherapy dosages on body surface area—for treating cancer does not work because…
What every nurse needs to know about breast cancer
Breast cancer strikes 1 in 8 American women. This article discusses recent diagnostic and treatment advances (including some you may not know about) that…
Give patients more than lip service: Manage oral mucositis with evidence-based interventions
The most widely recognized side effects of cancer treatment are hair loss and nausea, but 40% of patients also experience oral mucositis (Beck, 2004),…
When cancer spreads to the bone
Bone metastases causes significant pain and raises the risk of fractures and spinal-cord compression. Learn how to help patients cope.
Risks pf BSGI and PEM studies
According to a study in Radiology, a single breast-specific gamma imaging (BSGI) or positron emission mammography (PEM) test is “associated with a fatal radiation-induced…
Avastin may lose metastatic breast cancer indication
An U.S. Food and Drug Administration (FDA)-advisory panel has voted to strip Avastin’s indication for metastatic breast cancer because the drug is not effective…
In some situations, axillary node removal doesn’t improve breast cancer survival
A study presented at the American Society of Clinical Oncology June meeting found that removing additional axillary lymph nodes to look for breast cancer…
How to fight fatigue in patients with cancer
“Cancer’s paint box includes many shades of fatigue.” —Dana Jennings, a patient with prostate cancer who blogs for The New York Times The shock…
Intraperitoneal chemotherapy: Improving the odds for ovarian cancer patients
Patients with ovarian cancer may receive intraperitoneal (IP) chemotherapy, which delivers chemotherapeutic agents directly into the peritoneal cavity. Drugs given by this route include…
FDA recommends removing Avastin’s breast cancer indication
The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because…
Evidence-based interventions for depression in patients with cancer
Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society. Dana Jennings, in his New…
New warning added for gonadotropin-releasing hormone agonists
The U.S. Food and Drug Administration has asked manufacturers to add new labeling warnings for gonadotropin-releasing hormone (GnRH) agonists, mostly used to…
The role of pharmacogenomics in cancer
Oncology nurses have long appreciated that the “one size fits all” strategy—basing chemotherapy dosages on body surface area—for treating cancer does not…
What every nurse needs to know about breast cancer
Breast cancer strikes 1 in 8 American women. This article discusses recent diagnostic and treatment advances (including some you may not know…
Give patients more than lip service: Manage oral mucositis with evidence-based interventions
The most widely recognized side effects of cancer treatment are hair loss and nausea, but 40% of patients also experience oral mucositis…
When cancer spreads to the bone
Bone metastases causes significant pain and raises the risk of fractures and spinal-cord compression. Learn how to help patients cope.
Risks pf BSGI and PEM studies
According to a study in Radiology, a single breast-specific gamma imaging (BSGI) or positron emission mammography (PEM) test is “associated with a…
Avastin may lose metastatic breast cancer indication
An U.S. Food and Drug Administration (FDA)-advisory panel has voted to strip Avastin’s indication for metastatic breast cancer because the drug is…
In some situations, axillary node removal doesn’t improve breast cancer survival
A study presented at the American Society of Clinical Oncology June meeting found that removing additional axillary lymph nodes to look for…
How to fight fatigue in patients with cancer
“Cancer’s paint box includes many shades of fatigue.” —Dana Jennings, a patient with prostate cancer who blogs for The New York Times…
Intraperitoneal chemotherapy: Improving the odds for ovarian cancer patients
Patients with ovarian cancer may receive intraperitoneal (IP) chemotherapy, which delivers chemotherapeutic agents directly into the peritoneal cavity. Drugs given by this…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.